Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Scientific Director
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles  Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer

 

Dan Roach

Dan RoachDan joined PA Consulting Group in 1985, becoming Business Development Manager for the Biotechnology Group. In 1993, he joined Advanced Technology Management Limited (ATM), a company established by Alan Goodman which has been involved in forming and seeding nine companies, seven of which subsequently listed on Stock Exchanges - Acambis, Chiroscience, CeNeS, Core, Lidco, Oxford Biomedica and Salix.
 

He was a co-founder of Peptide Therapeutics (now Acambis) in 1993 where he was Commercial Director, CeNeS in 1996 where he was CEO from 1997-2002, Amura in 1997 and Avlar in 1998. He is currently an investment director of Avlar, the ATM group of companies, and on the Board of several Avlar investment companies.

 

He is Entrepreneur in Residence at the Centre for Entrepreneurial Learning and to the Greater Cambridge Partnership (GCP) Operating Board. Dan has been a board trustee of the Babraham Institute and Chairman of ERBI. He was one of the first students to read biochemistry at the University of Swansea and has a PhD in enzymology from Bath University, funded by Porton Down.